Literature DB >> 14979731

Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2).

Christian M Paumi1, Pamela K Smitherman, Alan J Townsend, Charles S Morrow.   

Abstract

15-Deoxy-Delta(12,14)prostaglandin J(2) (15-d-PGJ(2)), a terminal metabolite of the J-series cyclopentenone prostaglandins, influences a variety of cellular processes including gene expression, differentiation, growth, and apoptosis. As a ligand of peroxisomal proliferator-activated receptor gamma (PPAR gamma), 15-d-PGJ(2) can transactivate PPAR gamma-responsive promoters. Previously, we showed that multidrug resistance proteins MRP1 and MRP3 attenuate cytotoxic and transactivating activities of 15-d-PGJ(2) in MCF7 breast cancer cells. Attenuation was glutathione-dependent and was associated with formation of the glutathione conjugate of 15-d-PGJ(2), 15-d-PGJ(2)-SG, and its active efflux by MRP. Here we have investigated whether the glutathione S-transferases (GST) can influence biological activities of 15-d-PGJ(2). MCF7 cells were stably transduced with human cytosolic GST isozymes M1a, A1, or P1a. These GSTs had no effect on 15-d-PGJ(2) cytotoxicity when expressed either alone or in combination with MRP1. However, expression of any of the three GSTs significantly inhibited 15-d-PGJ(2)-dependent transactivation of a PPAR gamma-responsive reporter gene. The degree of inhibition correlated with the level of GST expressed. Under physiologic conditions, the nonenzymatic rate of 15-d-PGJ(2) conjugation with glutathione was significant. Of the three GST isozymes, only GSTM1a-1a further stimulated the rate of 15-d-PGJ(2)-SG formation. Moreover, GSTM1a-1a rate enhancement was only a transient burst that was complete within 15 s. Hence, catalysis plays little, if any, role in GST inhibition of 15-d-PGJ(2)-dependent transactivation. In contrast, inhibition of transactivation was associated with strong GST/15-d-PGJ(2) interactions. Potent inhibition by 15-d-PGJ(2) and 15-d-PGJ(2)-SG of GST activity was observed with K(i) in the 0.15-2.0 microM range for the three GST isozymes, results suggesting avid associations between GST and 15-d-PGJ(2) or 15-d-PGJ(2)-SG. Electrospray ionization mass spectrometry (ESI/MS) studies revealed no stable adducts of GST and 15-d-PGJ(2) indicating that GST/15-d-PGJ(2) interactions are primarily noncovalent. These results are consistent with a mechanism of GST-mediated inhibition of transactivation in which GST binds 15-d-PGJ(2) and 15-d-PGJ(2)-SG thereby sequestering the ligands in the cytosol away from their nuclear target, PPAR gamma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14979731     DOI: 10.1021/bi035936+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1).

Authors:  Lisa P Rudd; Sandra L Kabler; Charles S Morrow; Alan J Townsend
Journal:  Chem Biol Interact       Date:  2011-09-08       Impact factor: 5.192

2.  Evolution of Negative Cooperativity in Glutathione Transferase Enabled Preservation of Enzyme Function.

Authors:  Alessio Bocedi; Raffaele Fabrini; Mario Lo Bello; Anna Maria Caccuri; Giorgio Federici; Bengt Mannervik; Athel Cornish-Bowden; Giorgio Ricci
Journal:  J Biol Chem       Date:  2016-11-04       Impact factor: 5.157

3.  GSTM1 Deletion Exaggerates Kidney Injury in Experimental Mouse Models and Confers the Protective Effect of Cruciferous Vegetables in Mice and Humans.

Authors:  Joseph C Gigliotti; Adrienne Tin; Shirin Pourafshar; Sylvia Cechova; Yves T Wang; Sun-Sang J Sung; Gabor Bodonyi-Kovacs; Janet V Cross; Guang Yang; Nhu Nguyen; Fang Chan; Casey Rebholz; Bing Yu; Megan L Grove; Morgan E Grams; Anna Köttgen; Robert Scharpf; Phillip Ruiz; Eric Boerwinkle; Josef Coresh; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2019-11-14       Impact factor: 10.121

4.  Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK).

Authors:  Jamison Chang; Jennie Z Ma; Qing Zeng; Sylvia Cechova; Adam Gantz; Caroline Nievergelt; Daniel O'Connor; Michael Lipkowitz; Thu H Le
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

5.  Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.

Authors:  Christina Peklak-Scott; Pamela K Smitherman; Alan J Townsend; Charles S Morrow
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

6.  Noncatalytic interactions between glutathione S-transferases and nitroalkene fatty acids modulate nitroalkene-mediated activation of peroxisomal proliferator-activated receptor gamma.

Authors:  Darcy J P Bates; Mark O Lively; Michael J Gorczynski; S Bruce King; Alan J Townsend; Charles S Morrow
Journal:  Biochemistry       Date:  2009-05-19       Impact factor: 3.162

7.  Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction.

Authors:  Joo Yeun Oh; Niroshini Giles; Aimee Landar; Victor Darley-Usmar
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

8.  Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers.

Authors:  Tamara R Knight; Supratim Choudhuri; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-22       Impact factor: 4.849

9.  Biochemical warfare on the reef: the role of glutathione transferases in consumer tolerance of dietary prostaglandins.

Authors:  Kristen E Whalen; Amy L Lane; Julia Kubanek; Mark E Hahn
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

Review 10.  Getting the Message? Native Reactive Electrophiles Pass Two Out of Three Thresholds to be Bona Fide Signaling Mediators.

Authors:  Jesse R Poganik; Marcus J C Long; Yimon Aye
Journal:  Bioessays       Date:  2018-03-30       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.